|
|
Blood, 15 April 2004, Vol. 103, No. 8, pp. 3192-3199.
Prepublished online as a Blood First Edition Paper on December 30, 2003; DOI 10.1182/blood-2003-10-3722.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9
Chi Wai So,
Holger Karsunky,
Piu Wong,
Irving L. Weissman, and
Michael L. Cleary
From the Department of Pathology, Stanford University School of Medicine, CA.
Differential expression of Hox genes is associated with normal hematopoiesis, whereas inappropriate maintenance of Hox gene expression, particularly Hoxa7 and Hoxa9, is a feature of leukemias harboring mixed-lineage leukemia (MLL) mutations. To understand the pathogenic roles of Hox genes in MLL leukemias, we assessed the impact of Hoxa7 or Hoxa9 nullizygosity on hematopoietic progenitor compartments and their susceptibility to MLL-induced leukemias. Selective reductions in the absolute numbers of committed progenitors, but not of hematopoietic stem cells, distinguished Hoxa7- and Hoxa9-deficient mice. Megakaryocytic/erythroid progenitor (MEP) reductions in Hoxa7-/-mice correlated with reticulocytosis and thrombocytopenia without anemia. Conversely, Hoxa9-/- mice displayed marked lymphopenia and substantial reductions of common lymphoid progenitors (CLPs) and lymphoid precursors, in addition to significant reductions of common myeloid progenitors (CMPs) and granulocyte/monocyte progenitors (GMPs). In retroviral transduction/transplantation assays, Hoxa7- and Hoxa9-deficient progenitors remained susceptible to transformation by MLL-GAS7, which activates MLL through a dimerization-dependent mechanism. However, Hoxa7-/- or Hoxa9-/- progenitors were less efficient in generating transformed blast colony-forming units (CFUs) in vitro and induced leukemias with longer disease latencies, reduced penetrance, and less mature phenotypes. Thus, Hoxa7 and Hoxa9 contribute to hematopoietic progenitor homeostasis but are not necessary for MLL-GAS7–mediated leukemogenesis, yet they appear to affect disease latency, penetrance, and phenotypes consistent with their critical roles as downstream targets of MLL fusion proteins. (Blood. 2004;103:3192-3199)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
MLL, Hox genes, and leukemia: the plot thickens
- Jay L. Hess
Blood 2004 103: 2870-2871.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
H. Haeno, R. L. Levine, D. G. Gilliland, and F. Michor
A progenitor cell origin of myeloid malignancies
PNAS,
September 29, 2009;
106(39):
16616 - 16621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Faber, A. V. Krivtsov, M. C. Stubbs, R. Wright, T. N. Davis, M. van den Heuvel-Eibrink, C. M. Zwaan, A. L. Kung, and S. A. Armstrong
HOXA9 is required for survival in human MLL-rearranged acute leukemias
Blood,
March 12, 2009;
113(11):
2375 - 2385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Maillard, Y.-X. Chen, A. Friedman, Y. Yang, A. T. Tubbs, O. Shestova, W. S. Pear, and X. Hua
Menin regulates the function of hematopoietic stem cells and lymphoid progenitors
Blood,
February 19, 2009;
113(8):
1661 - 1669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Hongling Du and H. S. Taylor
Reviews: Stem Cells and Female Reproduction
Reproductive Sciences,
February 1, 2009;
16(2):
126 - 139.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Wang, S. Lindsey, I. Konieczna, L. Bei, E. Horvath, W. Huang, G. Saberwal, and E. A. Eklund
Constitutively Active SHP2 Cooperates with HoxA10 Overexpression to Induce Acute Myeloid Leukemia
J. Biol. Chem.,
January 23, 2009;
284(4):
2549 - 2567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Harper and P. D. Aplan
Chromosomal Rearrangements Leading to MLL Gene Fusions: Clinical and Biological Aspects
Cancer Res.,
December 15, 2008;
68(24):
10024 - 10027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Wong, M. Iwasaki, T. C.P. Somervaille, C. W. E. So, and M. L. Cleary
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Genes & Dev.,
November 1, 2007;
21(21):
2762 - 2774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Magnusson, A. C. M. Brun, N. Miyake, J. Larsson, M. Ehinger, J. M. Bjornsson, A. Wutz, M. Sigvardsson, and S. Karlsson
HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development
Blood,
May 1, 2007;
109(9):
3687 - 3696.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lindsey, W. Huang, H. Wang, E. Horvath, C. Zhu, and E. A. Eklund
Activation of SHP2 Protein-tyrosine Phosphatase Increases HoxA10-induced Repression of the Genes Encoding gp91PHOX and p67PHOX
J. Biol. Chem.,
January 26, 2007;
282(4):
2237 - 2249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Santillan, C. M. Theisler, A. S. Ryan, R. Popovic, T. Stuart, M.-M. Zhou, S. Alkan, and N. J. Zeleznik-Le
Bromodomain and Histone Acetyltransferase Domain Specificities Control Mixed Lineage Leukemia Phenotype.
Cancer Res.,
October 15, 2006;
66(20):
10032 - 10039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Bailey, H. Willenbring, S. Jiang, D. A. Anderson, D. A. Schroeder, M. H. Wong, M. Grompe, and W. H. Fleming
From the Cover: Myeloid lineage progenitors give rise to vascular endothelium
PNAS,
August 29, 2006;
103(35):
13156 - 13161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Chen, Q. Li, W. A. Hudson, A. Kumar, N. Kirchhof, and J. H. Kersey
A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy
Blood,
July 15, 2006;
108(2):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Katsumoto, Y. Aikawa, A. Iwama, S. Ueda, H. Ichikawa, T. Ochiya, and I. Kitabayashi
MOZ is essential for maintenance of hematopoietic stem cells.
Genes & Dev.,
May 15, 2006;
20(10):
1321 - 1330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Lawrence, J. Christensen, S. Fong, Y.-L. Hu, I. Weissman, G. Sauvageau, R. K. Humphries, and C. Largman
Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells
Blood,
December 1, 2005;
106(12):
3988 - 3994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Horton, D. G. Grier, G. J. McGonigle, A. Thompson, M. Morrow, I. De Silva, D. A. Moulding, D. Kioussis, T. R.J. Lappin, H. J.M. Brady, et al.
Continuous MLL-ENL Expression Is Necessary to Establish a "Hox Code" and Maintain Immortalization of Hematopoietic Progenitor Cells
Cancer Res.,
October 15, 2005;
65(20):
9245 - 9252.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Soulier, E. Clappier, J.-M. Cayuela, A. Regnault, M. Garcia-Peydro, H. Dombret, A. Baruchel, M.-L. Toribio, and F. Sigaux
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
Blood,
July 1, 2005;
106(1):
274 - 286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Ross, R. Mahfouz, M. Onciu, H.-C. Liu, X. Zhou, G. Song, S. A. Shurtleff, S. Pounds, C. Cheng, J. Ma, et al.
Gene expression profiling of pediatric acute myelogenous leukemia
Blood,
December 1, 2004;
104(12):
3679 - 3687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. So and M. L. Cleary
Dimerization: a versatile switch for oncogenesis
Blood,
August 15, 2004;
104(4):
919 - 922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Yokoyama, Z. Wang, J. Wysocka, M. Sanyal, D. J. Aufiero, I. Kitabayashi, W. Herr, and M. L. Cleary
Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression
Mol. Cell. Biol.,
July 1, 2004;
24(13):
5639 - 5649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
